{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:12Z","timestamp":1792785012297,"version":"4.5.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Health Care Commission of Sichuan Province","award":["Chuanganyan2023-220"],"award-info":[{"award-number":["Chuanganyan2023-220"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-80727-1","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T19:08:38Z","timestamp":1733425718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic value of the platelet, neutrophil, monocyte, basophil, and eosinophil to lymphocyte ratios in patients with severe community-acquired pneumonia (SCAP)"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1689-0303","authenticated-orcid":false,"given":"Xiao-Jiao","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9200-9269","authenticated-orcid":false,"given":"Bo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2138-271X","authenticated-orcid":false,"given":"Ke-Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Qian","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6435-0358","authenticated-orcid":false,"given":"Jian-Cheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0031-2667","authenticated-orcid":false,"given":"Shan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1640-155X","authenticated-orcid":false,"given":"Xin-Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6499-9461","authenticated-orcid":false,"given":"Zhu-Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6747-8592","authenticated-orcid":false,"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6814-3866","authenticated-orcid":false,"given":"Xiaoqing","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"80727_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13054-016-1414-2","volume":"20","author":"J Phua","year":"2016","unstructured":"Phua, J. et al. Severe community-acquired pneumonia: timely management measures in the first 24 hours. Crit. Care 20, 237. https:\/\/doi.org\/10.1186\/s13054-016-1414-2 (2016).","journal-title":"Crit. Care"},{"key":"80727_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s13054-021-03841-w","volume":"25","author":"D Huang","year":"2021","unstructured":"Huang, D. et al. Clinical characteristics and risk factors associated with mortality in patients with severe community-acquired pneumonia and type 2 diabetes mellitus. Crit. Care 25, 419. https:\/\/doi.org\/10.1186\/s13054-021-03841-w (2021).","journal-title":"Crit. Care"},{"key":"80727_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2147\/copd.S447519","volume":"19","author":"QQ Liao","year":"2024","unstructured":"Liao, Q. Q. et al. Platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and Eosinophil-to-lymphocyte ratio (ELR) as biomarkers in patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD). Int. J. Chronic Obstr. Pulm. Dis. 19, 501\u2013518. https:\/\/doi.org\/10.2147\/copd.S447519 (2024).","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"80727_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/1759-7714.12454","volume":"8","author":"C Yuan","year":"2017","unstructured":"Yuan, C. et al. Elevated pretreatment neutrophil\/white blood cell ratio and monocyte\/lymphocyte ratio predict poor survival in patients with curatively resected non-small cell lung cancer: results from a large cohort. Thorac. Cancer. 8, 350\u2013358. https:\/\/doi.org\/10.1111\/1759-7714.12454 (2017).","journal-title":"Thorac. Cancer"},{"key":"80727_CR5","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00408-020-00386-7","volume":"198","author":"A Zinellu","year":"2020","unstructured":"Zinellu, A. et al. Blood cell count derived inflammation indexes in patients with idiopathic pulmonary fibrosis. Lung 198, 821\u2013827. https:\/\/doi.org\/10.1007\/s00408-020-00386-7 (2020).","journal-title":"Lung"},{"key":"80727_CR6","doi-asserted-by":"publisher","unstructured":"Citu, C. et al. The predictive role of NLR, d-NLR, MLR, and SIRI in COVID-19 mortality. Diagnostics https:\/\/doi.org\/10.3390\/diagnostics12010122 (2022).","DOI":"10.3390\/diagnostics12010122"},{"key":"80727_CR7","doi-asserted-by":"publisher","first-page":"822556","DOI":"10.3389\/fcvm.2022.822556","volume":"9","author":"M Fors","year":"2022","unstructured":"Fors, M. et al. Sex-dependent performance of the neutrophil-to-Lymphocyte, monocyte-to-Lymphocyte, platelet-to-lymphocyte and Mean platelet volume-to-platelet ratios in discriminating COVID-19 severity. Front. Cardiovasc. Med. 9, 822556. https:\/\/doi.org\/10.3389\/fcvm.2022.822556 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"80727_CR8","doi-asserted-by":"publisher","unstructured":"Qi, X., Dong, Y., Lin, X. & Xin, W. Value of neutrophil to lymphocyte ratio, platelet to Lymphocyte Ratio, and red blood cell distribution width in evaluating the prognosis of children with severe pneumonia. Evid. Based Complement. Alternat Med. 2021, 1818469. https:\/\/doi.org\/10.1155\/2021\/1818469 (2021).","DOI":"10.1155\/2021\/1818469"},{"key":"80727_CR9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/apm.12722","volume":"125","author":"Z Yang","year":"2017","unstructured":"Yang, Z. et al. Comparisons of neutrophil-, monocyte-, eosinophil-, and basophil- lymphocyte ratios among various systemic autoimmune rheumatic diseases. APMIS 125, 863\u2013871. https:\/\/doi.org\/10.1111\/apm.12722 (2017).","journal-title":"APMIS"},{"key":"80727_CR10","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1007\/s00405-016-3980-y","volume":"273","author":"N Bozan","year":"2016","unstructured":"Bozan, N. et al. Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds. Eur. Arch. Otorhinolaryngol. 273, 3663\u20133672. https:\/\/doi.org\/10.1007\/s00405-016-3980-y (2016).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"80727_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/jcla.21908","volume":"30","author":"R Mercan","year":"2016","unstructured":"Mercan, R. et al. The Association between Neutrophil\/Lymphocyte Ratio and Disease Activity in Rheumatoid Arthritis and Ankylosing Spondylitis. J. Clin. Lab. Anal. 30, 597\u2013601. https:\/\/doi.org\/10.1002\/jcla.21908 (2016).","journal-title":"J. Clin. Lab. Anal."},{"key":"80727_CR12","doi-asserted-by":"publisher","first-page":"830642","DOI":"10.3389\/fsurg.2022.830642","volume":"9","author":"K Wang","year":"2022","unstructured":"Wang, K. et al. The Prognostic Value of multiple systemic inflammatory biomarkers in preoperative patients with non-small cell Lung Cancer. Front. Surg. 9, 830642. https:\/\/doi.org\/10.3389\/fsurg.2022.830642 (2022).","journal-title":"Front. Surg."},{"key":"80727_CR13","doi-asserted-by":"publisher","unstructured":"Hadadi, A. et al. Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer. Urol. Oncol. 40 (271 e279-271 e218). https:\/\/doi.org\/10.1016\/j.urolonc.2022.03.016 (2022).","DOI":"10.1016\/j.urolonc.2022.03.016"},{"issue":"Suppl 2","key":"80727_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1086\/511159","volume":"44","author":"LA Mandell","year":"2007","unstructured":"Mandell, L. A. et al. Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 44 (Suppl 2), 27\u201372. https:\/\/doi.org\/10.1086\/511159 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"80727_CR15","doi-asserted-by":"publisher","first-page":"n436","DOI":"10.1136\/bmj.n436","volume":"372","author":"AH Attaway","year":"2021","unstructured":"Attaway, A. H., Scheraga, R. G., Bhimraj, A., Biehl, M. & Hatipoglu, U. Severe covid-19 pneumonia: pathogenesis and clinical management. BMJ 372, n436. https:\/\/doi.org\/10.1136\/bmj.n436 (2021).","journal-title":"BMJ"},{"key":"80727_CR16","doi-asserted-by":"publisher","unstructured":"Martin-Loeches, I. et al. ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-023-07033-8 (2023).","DOI":"10.1007\/s00134-023-07033-8"},{"key":"80727_CR17","doi-asserted-by":"publisher","unstructured":"Martin-Loeches, I. et al. ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Eur. Respir J. https:\/\/doi.org\/10.1183\/13993003.00735-2022 (2023).","DOI":"10.1183\/13993003.00735-2022"},{"key":"80727_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/MCP.0000000000000671","volume":"26","author":"JP Metlay","year":"2020","unstructured":"Metlay, J. P. & Waterer, G. W. Update in adult community-acquired pneumonia: key points from the new American Thoracic Society\/Infectious Diseases Society of America 2019 guideline. Curr. Opin. Pulm Med. 26, 203\u2013207. https:\/\/doi.org\/10.1097\/MCP.0000000000000671 (2020).","journal-title":"Curr. Opin. Pulm Med."},{"key":"80727_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2020.09.001","volume":"82","author":"P Verdecchia","year":"2020","unstructured":"Verdecchia, P., Reboldi, G. & Angeli, F. The 2020 International Society of Hypertension global hypertension practice guidelines - key messages and clinical considerations. Eur. J. Intern. Med. 82, 1\u20136. https:\/\/doi.org\/10.1016\/j.ejim.2020.09.001 (2020).","journal-title":"Eur. J. Intern. Med."},{"key":"80727_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ccc.2013.03.009","volume":"29","author":"WI Sligl","year":"2013","unstructured":"Sligl, W. I. & Marrie, T. J. Severe community-acquired pneumonia. Crit. Care Clin. 29, 563\u2013601. https:\/\/doi.org\/10.1016\/j.ccc.2013.03.009 (2013).","journal-title":"Crit. Care Clin."},{"key":"80727_CR21","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay, J. P. et al. Diagnosis and treatment of adults with community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am. J. Respir Crit. Care Med. 200, e45\u2013e67. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST (2019).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"80727_CR22","doi-asserted-by":"publisher","unstructured":"Nair, G. B. & Niederman, M. S. Updates on community acquired pneumonia management in the ICU. Pharmacol. Ther. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107663 (2021).","DOI":"10.1016\/j.pharmthera.2020.107663"},{"key":"80727_CR23","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/s0140-6736(21)00630-9","volume":"398","author":"S Aliberti","year":"2021","unstructured":"Aliberti, S., Dela Cruz, C. S., Amati, F., Sotgiu, G. & Restrepo, M. I. Community-acquired pneumonia. Lancet 398, 906\u2013919. https:\/\/doi.org\/10.1016\/s0140-6736(21)00630-9 (2021).","journal-title":"Lancet"},{"key":"80727_CR24","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/cpdd.1112","volume":"11","author":"KW Zhu","year":"2022","unstructured":"Zhu, K. W. et al. Pharmacokinetics and bioequivalence of Two Formulations of Rosuvastatin Following Single-Dose Administration in Healthy Chinese Subjects under Fasted and Fed Conditions. Clin. Pharmacol. Drug Dev. 11, 987\u2013996. https:\/\/doi.org\/10.1002\/cpdd.1112 (2022).","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"80727_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1541-0420.2005.00389.x","volume":"62","author":"B Rosner","year":"2006","unstructured":"Rosner, B., Glynn, R. J. & Lee, M. L. The Wilcoxon signed rank test for paired comparisons of clustered data. Biometrics 62, 185\u2013192. https:\/\/doi.org\/10.1111\/j.1541-0420.2005.00389.x (2006).","journal-title":"Biometrics"},{"key":"80727_CR26","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4097\/kja.19087","volume":"72","author":"JH Kim","year":"2019","unstructured":"Kim, J. H. Multicollinearity and misleading statistical results. Korean J. Anesthesiol. 72, 558\u2013569. https:\/\/doi.org\/10.4097\/kja.19087 (2019).","journal-title":"Korean J. Anesthesiology"},{"key":"80727_CR27","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s11135-017-0584-6","volume":"52","author":"R Johnston","year":"2017","unstructured":"Johnston, R., Jones, K. & Manley, D. Confounding and collinearity in regression analysis: a cautionary tale and an alternative procedure, illustrated by studies of British voting behaviour. Qual. Quant. 52, 1957\u20131976. https:\/\/doi.org\/10.1007\/s11135-017-0584-6 (2017).","journal-title":"Qual. Quant."},{"key":"80727_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/00220973.2013.813360","volume":"82","author":"TM Beasley","year":"2013","unstructured":"Beasley, T. M. Tests of mediation: paradoxical decline in statistical power as a function of Mediator Collinearity. J. Exp. Educ. 82, 283\u2013306. https:\/\/doi.org\/10.1080\/00220973.2013.813360 (2013).","journal-title":"J. Experimental Educ."},{"key":"80727_CR29","doi-asserted-by":"publisher","unstructured":"Vatcheva, P., Lee, M. & K. & Multicollinearity in regression analyses conducted in epidemiologic studies. Epidemiol. Open Access 06 https:\/\/doi.org\/10.4172\/2161-1165.1000227 (2016).","DOI":"10.4172\/2161-1165.1000227"},{"key":"80727_CR30","doi-asserted-by":"publisher","unstructured":"van Schaik, P., Peng, Y., Ojelabi, A. & Ling, J. Explainable statistical learning in public health for policy development: the case of real-world suicide data. BMC Med. Res. Methodol. https:\/\/doi.org\/10.1186\/s12874-019-0796-7 (2019).","DOI":"10.1186\/s12874-019-0796-7"},{"key":"80727_CR31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s12325-023-02717-5","volume":"41","author":"K Lu","year":"2023","unstructured":"Lu, K. et al. Efficacy and safety of different doses of Rivaroxaban and Risk factors for bleeding in Elderly patients with venous thromboembolism: a Real-World, Multicenter, Observational, Cohort Study. Adv. Therapy. 41, 391\u2013412. https:\/\/doi.org\/10.1007\/s12325-023-02717-5 (2023).","journal-title":"Adv. Therapy"},{"key":"80727_CR32","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1177\/09622802211047346","volume":"30","author":"LJ Beesley","year":"2021","unstructured":"Beesley, L. J. et al. Multiple imputation with missing data indicators. Stat. Methods Med. Res. 30, 2685\u20132700. https:\/\/doi.org\/10.1177\/09622802211047346 (2021).","journal-title":"Stat. Methods Med. Res."},{"key":"80727_CR33","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1002\/sim.5328","volume":"31","author":"OV Demler","year":"2012","unstructured":"Demler, O. V., Pencina, M. J. & D\u2019Agostino, R. B. Misuse of DeLong test to compare AUCs for nested models. Stat. Med. 31, 2577\u20132587. https:\/\/doi.org\/10.1002\/sim.5328 (2012).","journal-title":"Stat. Med."},{"key":"80727_CR34","doi-asserted-by":"publisher","first-page":"913667","DOI":"10.3389\/fimmu.2022.913667","volume":"13","author":"QQ Liao","year":"2022","unstructured":"Liao, Q. Q. et al. Long-term prognostic factors in patients with Antineutrophil cytoplasmic antibody-Associated Vasculitis: a 15-Year Multicenter Retrospective Study. Front. Immunol. 13, 913667. https:\/\/doi.org\/10.3389\/fimmu.2022.913667 (2022).","journal-title":"Front. Immunol."},{"key":"80727_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/thorax.58.5.377","volume":"58","author":"WS Lim","year":"2003","unstructured":"Lim, W. S. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58, 377\u2013382. https:\/\/doi.org\/10.1136\/thorax.58.5.377 (2003).","journal-title":"Thorax"},{"key":"80727_CR36","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.emc.2018.07.001","volume":"36","author":"AC Rider","year":"2018","unstructured":"Rider, A. C. & Frazee, B. W. Community-Acquired Pneumonia. Emerg. Med. Clin. North Am. 36, 665\u2013683. https:\/\/doi.org\/10.1016\/j.emc.2018.07.001 (2018).","journal-title":"Emerg. Med Clin North Am."},{"key":"80727_CR37","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cca.2020.08.035","volume":"510","author":"J Tang","year":"2020","unstructured":"Tang, J. et al. Admission IL-32 concentration predicts severity and mortality of severe community-acquired pneumonia independently of etiology. Clin. Chim. Acta. 510, 647\u2013653. https:\/\/doi.org\/10.1016\/j.cca.2020.08.035 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"80727_CR38","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/intimm\/dxab021","volume":"33","author":"H Karasuyama","year":"2021","unstructured":"Karasuyama, H., Shibata, S., Yoshikawa, S. & Miyake, K. Basophils, a neglected minority in the immune system, have come into the limelight at last. Int. Immunol. 33, 809\u2013813. https:\/\/doi.org\/10.1093\/intimm\/dxab021 (2021).","journal-title":"Int. Immunol."},{"key":"80727_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2014.07.004","volume":"31","author":"H Karasuyama","year":"2014","unstructured":"Karasuyama, H. & Yamanishi, Y. Basophils have emerged as a key player in immunity. Curr. Opin. Immunol. 31, 1\u20137. https:\/\/doi.org\/10.1016\/j.coi.2014.07.004 (2014).","journal-title":"Curr. Opin. Immunol."},{"key":"80727_CR40","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/ni.f.217","volume":"9","author":"B Min","year":"2008","unstructured":"Min, B. Basophils: what they \u2018can do\u2019 versus what they \u2018actually do\u2019. Nat. Immunol. 9, 1333\u20131339. https:\/\/doi.org\/10.1038\/ni.f.217 (2008).","journal-title":"Nat. Immunol."},{"key":"80727_CR41","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/intimm\/dxy026","volume":"30","author":"H Karasuyama","year":"2018","unstructured":"Karasuyama, H., Miyake, K., Yoshikawa, S., Kawano, Y. & Yamanishi, Y. How do basophils contribute to Th2 cell differentiation and allergic responses? Int. Immunol. 30, 391\u2013396. https:\/\/doi.org\/10.1093\/intimm\/dxy026 (2018).","journal-title":"Int. Immunol."},{"key":"80727_CR42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejphar.2015.04.049","volume":"778","author":"C Schwartz","year":"2016","unstructured":"Schwartz, C., Eberle, J. U. & Voehringer, D. Basophils in inflammation. Eur. J. Pharmacol. 778, 90\u201395. https:\/\/doi.org\/10.1016\/j.ejphar.2015.04.049 (2016).","journal-title":"Eur. J. Pharmacol."},{"key":"80727_CR43","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1111\/jgh.15964","volume":"37","author":"K Inaba","year":"2022","unstructured":"Inaba, K. et al. Proinflammatory role of basophils in oxazolone-induced chronic intestinal inflammation. J. Gastroenterol. Hepatol. 37, 1768\u20131775. https:\/\/doi.org\/10.1111\/jgh.15964 (2022).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"80727_CR44","doi-asserted-by":"publisher","unstructured":"Pieralli, F. et al. Acute cardiovascular events in patients with community acquired pneumonia: results from the observational prospective FADOI-ICECAP study. BMC Infect. Dis. 21 https:\/\/doi.org\/10.1186\/s12879-021-05781-w (2021).","DOI":"10.1186\/s12879-021-05781-w"},{"key":"80727_CR45","doi-asserted-by":"publisher","unstructured":"Martin-Loeches, I. et al. A Multicentric Observational Study to Determine Myocardial Injury in Severe Community-Acquired Pneumonia (sCAP). Antibiotics. (2023). https:\/\/doi.org\/10.3390\/antibiotics12121710","DOI":"10.3390\/antibiotics12121710"},{"key":"80727_CR46","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1111\/crj.12791","volume":"12","author":"A Cilli","year":"2018","unstructured":"Cilli, A. et al. Acute cardiac events in severe community-acquired pneumonia: a multicenter study. Clin. Respir. J. 12, 2212\u20132219. https:\/\/doi.org\/10.1111\/crj.12791 (2018).","journal-title":"Clin. Respir J."},{"key":"80727_CR47","doi-asserted-by":"publisher","unstructured":"Anderson, R. & Feldman, C. The global burden of community-acquired pneumonia in adults, Encompassing Invasive Pneumococcal Disease and the prevalence of its Associated Cardiovascular events, with a focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms241311038 (2023).","DOI":"10.3390\/ijms241311038"},{"key":"80727_CR48","doi-asserted-by":"publisher","unstructured":"Tralhao, A. & Povoa, P. Cardiovascular events after community-acquired pneumonia: A global perspective with systematic review and Meta-analysis of Observational studies. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm9020414 (2020).","DOI":"10.3390\/jcm9020414"},{"key":"80727_CR49","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1378\/chest.15-0484","volume":"148","author":"C Feldman","year":"2015","unstructured":"Feldman, C., Anderson, R. & Community-Acquired, P. Pathogenesis of Acute Cardiac events and potential adjunctive therapies. Chest 148, 523\u2013532. https:\/\/doi.org\/10.1378\/chest.15-0484 (2015).","journal-title":"Chest"},{"key":"80727_CR50","doi-asserted-by":"publisher","unstructured":"Hoang Ngo, T. et al. The combination of CYP2C19 polymorphism and inflammatory cell ratios in prognosis cardiac adverse events after acute coronary syndrome. Int. J. Cardiol. Cardiovasc. Risk Prev. https:\/\/doi.org\/10.1016\/j.ijcrp.2023.200222 (2023).","DOI":"10.1016\/j.ijcrp.2023.200222"},{"key":"80727_CR51","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12872-020-01500-6","volume":"20","author":"J Larmann","year":"2020","unstructured":"Larmann, J. et al. Preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with major adverse cardiovascular and cerebrovascular events in coronary heart disease patients undergoing non-cardiac surgery. BMC Cardiovasc. Disord. 20, 230. https:\/\/doi.org\/10.1186\/s12872-020-01500-6 (2020).","journal-title":"BMC Cardiovasc. Disord"},{"key":"80727_CR52","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1177\/17085381211059383","volume":"31","author":"N Selcuk","year":"2023","unstructured":"Selcuk, N. et al. Sarcopenia is a risk factor for major adverse cardiac events after surgical revascularization for critical limb ischemia. Vascular 31, 64\u201371. https:\/\/doi.org\/10.1177\/17085381211059383 (2023).","journal-title":"Vascular"},{"key":"80727_CR53","doi-asserted-by":"publisher","first-page":"e026326","DOI":"10.1161\/JAHA.122.026326","volume":"12","author":"S Tamaki","year":"2023","unstructured":"Tamaki, S. et al. Combination of Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of Cardiac death in patients with Acute Decompensated Heart failure with preserved left ventricular ejection fraction: a Multicenter Study. J. Am. Heart Assoc. 12, e026326. https:\/\/doi.org\/10.1161\/JAHA.122.026326 (2023).","journal-title":"J. Am. Heart Assoc."},{"key":"80727_CR54","doi-asserted-by":"publisher","unstructured":"Kuikel, S. et al. Neutrophil\u2013lymphocyte ratio as a predictor of adverse outcome in patients with community-acquired pneumonia: a systematic review. Health Sci. Rep. https:\/\/doi.org\/10.1002\/hsr2.630 (2022).","DOI":"10.1002\/hsr2.630"},{"key":"80727_CR55","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00001432-200304000-00012","volume":"16","author":"JJ Oosterheert","year":"2003","unstructured":"Oosterheert, J. J., Bonten, M. J., Hak, E., Schneider, M. M. & Hoepelman A. I. severe community-acquired pneumonia: what\u2019s in a name? Curr. Opin. Infect. Dis. 16, 153\u2013159. https:\/\/doi.org\/10.1097\/00001432-200304000-00012 (2003).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"80727_CR56","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000479089","volume":"94","author":"J Almirall","year":"2017","unstructured":"Almirall, J., Serra-Prat, M., Bol\u00edbar, I. & Balasso, V. Risk factors for community-acquired pneumonia in adults: a systematic review of Observational studies. Respiration 94, 299\u2013311. https:\/\/doi.org\/10.1159\/000479089 (2017).","journal-title":"Respiration"},{"key":"80727_CR57","doi-asserted-by":"publisher","unstructured":"Wongsurakiat, P. & Chitwarakorn, N. Severe community-acquired pneumonia in general medical wards: outcomes and impact of initial antibiotic selection. BMC Pulm. Med. https:\/\/doi.org\/10.1186\/s12890-019-0944-1 (2019).","DOI":"10.1186\/s12890-019-0944-1"},{"key":"80727_CR58","doi-asserted-by":"publisher","unstructured":"Marti, C. et al. Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis. Crit. Care https:\/\/doi.org\/10.1186\/cc11447 (2012).","DOI":"10.1186\/cc11447"},{"key":"80727_CR59","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/QCO.0b013e3283368333","volume":"23","author":"SM Brown","year":"2010","unstructured":"Brown, S. M. & Dean, N. C. Defining and predicting severe community-acquired pneumonia. Curr. Opin. Infect. Dis. 23, 158\u2013164. https:\/\/doi.org\/10.1097\/QCO.0b013e3283368333 (2010).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"80727_CR60","doi-asserted-by":"publisher","unstructured":"Meng, Y., Zhang, L., Huang, M. & Sun, G. Blood heparin-binding protein and neutrophil-to-lymphocyte ratio as indicators of the severity and prognosis of community-acquired pneumonia. Respir. Med. https:\/\/doi.org\/10.1016\/j.rmed.2023.107144 (2023).","DOI":"10.1016\/j.rmed.2023.107144"},{"key":"80727_CR61","doi-asserted-by":"publisher","unstructured":"Liu, Q., Sun, G. & Huang, L. Association of the NLR, BNP, PCT, CRP, and D-D with the severity of community-acquired pneumonia in older adults. Clin. Lab. https:\/\/doi.org\/10.7754\/Clin.Lab.2023.220330 (2023).","DOI":"10.7754\/Clin.Lab.2023.220330"},{"key":"80727_CR62","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1007\/s10787-023-01273-2","volume":"31","author":"X Liu","year":"2023","unstructured":"Liu, X., Li, J., Sun, L., Wang, T. & Liang, W. The association between neutrophil-to-lymphocyte ratio and disease activity in rheumatoid arthritis. Inflammopharmacology. 31, 2237\u20132244. https:\/\/doi.org\/10.1007\/s10787-023-01273-2 (2023).","journal-title":"Inflammopharmacology"},{"key":"80727_CR63","doi-asserted-by":"publisher","first-page":"104598","DOI":"10.1016\/j.mvr.2023.104598","volume":"150","author":"A Garc\u00eda-Escobar","year":"2023","unstructured":"Garc\u00eda-Escobar, A. et al. Neutrophil-to-lymphocyte ratio an inflammatory biomarker, and prognostic marker in heart failure, cardiovascular disease and chronic inflammatory diseases: new insights for a potential predictor of anti-cytokine therapy responsiveness. Microvasc. Res. 150, 104598. https:\/\/doi.org\/10.1016\/j.mvr.2023.104598 (2023).","journal-title":"Microvasc. Res."},{"key":"80727_CR64","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4149\/bll_2021_078","volume":"122","author":"R Zahorec","year":"2021","unstructured":"Zahorec, R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratislava Med. J. 122, 474\u2013488. https:\/\/doi.org\/10.4149\/bll_2021_078 (2021).","journal-title":"Bratislava Med. J."},{"key":"80727_CR65","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.mayocp.2021.04.025","volume":"96","author":"M Wechsler","year":"2021","unstructured":"Wechsler, M. et al. (ed, E.) Eosinophils in Health and Disease: a state-of-the-art review. Mayo Clin. Proc. 96 2694\u20132707 https:\/\/doi.org\/10.1016\/j.mayocp.2021.04.025 (2021).","journal-title":"Mayo Clin. Proc."},{"key":"80727_CR66","doi-asserted-by":"publisher","unstructured":"Macchia, I. et al. Eosinophils as potential biomarkers in respiratory viral infections. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1170035 (2023).","DOI":"10.3389\/fimmu.2023.1170035"},{"key":"80727_CR67","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s12016-015-8525-4","volume":"50","author":"KA Ravin","year":"2015","unstructured":"Ravin, K. A. & Loy, M. The Eosinophil in infection. Clin. Rev. Allergy Immunol. 50, 214\u2013227. https:\/\/doi.org\/10.1007\/s12016-015-8525-4 (2015).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"80727_CR68","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ccm.2016.04.015","volume":"37","author":"V Cottin","year":"2016","unstructured":"Cottin, V. Eosinophilic Lung diseases. Clin. Chest. Med. 37, 535\u2013556. https:\/\/doi.org\/10.1016\/j.ccm.2016.04.015 (2016).","journal-title":"Clin. Chest. Med."},{"key":"80727_CR69","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jaci.2017.09.022","volume":"141","author":"JA O\u2019Sullivan","year":"2018","unstructured":"O\u2019Sullivan, J. A. & Bochner, B. S. Eosinophils and eosinophil-associated diseases: an update. J. Allergy Clin. Immunol. 141, 505\u2013517. https:\/\/doi.org\/10.1016\/j.jaci.2017.09.022 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"80727_CR70","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2147\/copd.S396311","volume":"18","author":"J Pu","year":"2023","unstructured":"Pu, J. et al. Blood eosinophils and clinical outcomes in inpatients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: a prospective cohort study. Int. J. Chronic Obstr. Pulm. Dis. 18, 169\u2013179. https:\/\/doi.org\/10.2147\/copd.S396311 (2023).","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"80727_CR71","doi-asserted-by":"publisher","unstructured":"Kolsum, U. et al. Blood and sputum eosinophils in COPD; relationship with bacterial load. Respir. Res. https:\/\/doi.org\/10.1186\/s12931-017-0570-5 (2017).","DOI":"10.1186\/s12931-017-0570-5"},{"key":"80727_CR72","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2147\/copd.S197361","volume":"14","author":"J Choi","year":"2019","unstructured":"Choi, J. et al. The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease. Int. J. Chronic Obstr. Pulm. Dis. 14, 953\u2013959. https:\/\/doi.org\/10.2147\/copd.S197361 (2019).","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"80727_CR73","doi-asserted-by":"publisher","unstructured":"Loukides, S. et al. Independent factors associate with hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease requiring intensive care unit admission: focusing on the eosinophil-to-neutrophil ratio. Plos One https:\/\/doi.org\/10.1371\/journal.pone.0218932 (2019).","DOI":"10.1371\/journal.pone.0218932"},{"key":"80727_CR74","doi-asserted-by":"publisher","first-page":"107501","DOI":"10.1016\/j.rmed.2023.107501","volume":"222","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. The association between blood eosinophils and clinical outcome of acute exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir. Med. 222, 107501. https:\/\/doi.org\/10.1016\/j.rmed.2023.107501 (2024).","journal-title":"Respir. Med."},{"key":"80727_CR75","doi-asserted-by":"publisher","unstructured":"Qiu, Y. et al. Neutrophil-to-Lymphocyte Ratio Predicts Mortality in Adult Renal Transplant Recipients with Severe Community-Acquired Pneumonia. Pathogens (2020). https:\/\/doi.org\/10.3390\/pathogens9110913","DOI":"10.3390\/pathogens9110913"},{"key":"80727_CR76","doi-asserted-by":"publisher","unstructured":"Mujakovic, A. et al. Can neutrophil-to-lymphocyte ratio and proatherogenic risk factors improve the accuracy of pneumonia severity index in the prediction of community acquired pneumonia outcome in healthy individuals? Med. Glas (Zenica)  https:\/\/doi.org\/10.17392\/1464-22 (2022).","DOI":"10.17392\/1464-22"},{"key":"80727_CR77","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-023-01992-2","author":"CC Enersen","year":"2023","unstructured":"Enersen, C. C. et al. The ratio of neutrophil-to-lymphocyte and platelet-to-lymphocyte and association with mortality in community-acquired pneumonia: a derivation-validation cohort study. Infection https:\/\/doi.org\/10.1007\/s15010-023-01992-2 (2023).","journal-title":"Infection"},{"key":"80727_CR78","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s40520-022-02301-x","volume":"35","author":"LH Zhao","year":"2023","unstructured":"Zhao, L. H., Chen, J. & Zhu, R. X. The relationship between frailty and community-acquired pneumonia in older patients. Aging Clin. Exp. Res. 35, 349\u2013355. https:\/\/doi.org\/10.1007\/s40520-022-02301-x (2023).","journal-title":"Aging Clin. Exp. Res."},{"key":"80727_CR79","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/MD.0b013e318210504c","volume":"90","author":"D Viasus","year":"2011","unstructured":"Viasus, D. et al. Community-acquired pneumonia in patients with liver cirrhosis. Medicine 90, 110\u2013118. https:\/\/doi.org\/10.1097\/MD.0b013e318210504c (2011).","journal-title":"Medicine"},{"key":"80727_CR80","doi-asserted-by":"publisher","unstructured":"Gjura\u0161in, B., Jeli\u010di\u0107, M., Kutle\u0161a, M. & Papi\u0107, N. The impact of nonalcoholic fatty liver disease on severe community-acquired pneumonia outcomes. Life https:\/\/doi.org\/10.3390\/life13010036 (2022).","DOI":"10.3390\/life13010036"},{"key":"80727_CR81","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/qjmed\/hcy227","volume":"112","author":"WB Nseir","year":"2019","unstructured":"Nseir, W. B., Mograbi, J. M., Amara, A. E., Abu Elheja, O. H. & Mahamid, M. N. non-alcoholic fatty liver disease and 30-day all-cause mortality in adult patients with community-acquired pneumonia. QJM: Int. J. Med. 112, 95\u201399. https:\/\/doi.org\/10.1093\/qjmed\/hcy227 (2019).","journal-title":"QJM: Int. J. Med."},{"key":"80727_CR82","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2021.7896\/2021","author":"E Ferrer-Inaebnit","year":"2021","unstructured":"Ferrer-Inaebnit, E., Molina-Romero, F. X., Segura-Sampedro, J. J., Gonz\u00e1lez-Argent\u00e9, X. & Mor\u00f3n Canis, J. M. A review of the diagnosis and management of liver hydatid cyst. Rev. Espa\u00f1ola Enferm. Dig.. https:\/\/doi.org\/10.17235\/reed.2021.7896\/2021 (2021).","journal-title":"Revista Espa\u00f1ola De Enfermedades Digestivas"},{"key":"80727_CR83","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10735-020-09898-1","volume":"51","author":"MJ Sun","year":"2020","unstructured":"Sun, M. J., Cao, Z. Q. & Leng, P. The roles of galectins in hepatic diseases. J. Mol. Histol. 51, 473\u2013484. https:\/\/doi.org\/10.1007\/s10735-020-09898-1 (2020).","journal-title":"J. Mol. Histol."},{"key":"80727_CR84","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1056\/nejm200004273421707","volume":"342","author":"DS Pratt","year":"2000","unstructured":"Pratt, D. S. & Kaplan, M. M. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N. Engl. J. Med. 342, 1266\u20131271. https:\/\/doi.org\/10.1056\/nejm200004273421707 (2000).","journal-title":"N. Engl. J. Med."},{"key":"80727_CR85","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/0885066614554897","volume":"31","author":"NZ Kubilay","year":"2014","unstructured":"Kubilay, N. Z., Sengel, B. E., Wood, K. E. & Layon, A. J. Biomarkers in hepatic disease. J. Intensive Care Med. 31, 104\u2013112. https:\/\/doi.org\/10.1177\/0885066614554897 (2014).","journal-title":"J. Intensive Care Med."},{"key":"80727_CR86","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jceh.2018.06.003","volume":"9","author":"S Najmy","year":"2019","unstructured":"Najmy, S. et al. Redefining the normal values of serum aminotransferases in healthy Indian males. J. Clin. Exp. Hepatol. 9, 191\u2013199. https:\/\/doi.org\/10.1016\/j.jceh.2018.06.003 (2019).","journal-title":"J. Clin. Experimental Hepatol."},{"key":"80727_CR87","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1440-1746.2012.07143.x","volume":"28","author":"W Sohn","year":"2013","unstructured":"Sohn, W. et al. Upper limit of normal serum alanine and aspartate aminotransferase levels in Korea. J. Gastroenterol. Hepatol. 28, 522\u2013529. https:\/\/doi.org\/10.1111\/j.1440-1746.2012.07143.x (2013).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"80727_CR88","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1242\/jeb.01172","volume":"207","author":"GA Ordway","year":"2004","unstructured":"Ordway, G. A. & Garry, D. J. Myoglobin: an essential hemoprotein in striated muscle. J. Exp. Biol. 207, 3441\u20133446. https:\/\/doi.org\/10.1242\/jeb.01172 (2004).","journal-title":"J. Exp. Biol."},{"key":"80727_CR89","doi-asserted-by":"publisher","first-page":"114624","DOI":"10.1016\/j.jpba.2022.114624","volume":"211","author":"SK Asl","year":"2022","unstructured":"Asl, S. K. & Rahimzadegan, M. The recent progress in the early diagnosis of acute myocardial infarction based on myoglobin biomarker: Nano-aptasensors approaches. J. Pharm. Biomed. Anal. 211, 114624. https:\/\/doi.org\/10.1016\/j.jpba.2022.114624 (2022).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"80727_CR90","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/TA.0b013e318256999d","volume":"73","author":"J Juern","year":"2012","unstructured":"Juern, J., Khatri, V. & Weigelt, J. Base excess: a review. J. Trauma. Acute Care Surg. 73, 27\u201332. https:\/\/doi.org\/10.1097\/TA.0b013e318256999d (2012).","journal-title":"J. Trauma. Acute Care Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80727-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80727-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80727-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T20:03:06Z","timestamp":1733428986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80727-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["80727"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-80727-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3113759\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-3706339\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]},"assertion":[{"value":"4 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author Ke-Wei Zhu is employed by GuangZhou BaiYunShan Pharmaceutical Holdings CO.,LTD. BaiYunShan Pharmaceutical General Factory, Guangzhou, China. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30406"}}